BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Talks.cam//talks.cam.ac.uk//
X-WR-CALNAME:Talks.cam
BEGIN:VEVENT
SUMMARY:The 2014 Alzheimer's Disease Congress - See website for details- w
 ww.regonline.co.uk/Alz2014
DTSTART:20140623T080000Z
DTEND:20140623T160000Z
UID:TALK51721@talks.cam.ac.uk
CONTACT:Speaker to be confirmed
DESCRIPTION:This three day event will discuss aspects of  Alzheimer's Dise
 ase development and treatment in an informal academic setting. This year t
 here are three main topics for discussion:\n\n* Biomarker Discovery and As
 say Development \n* Prevention Strategies and Vaccine Development \n* Drug
  Discovery and Development \n\nWith plenty of opportunity  for networking 
 and debate\, this informal international  meeting will bring you up to dat
 e with current research and thinking regarding Alzheimer's Disease.\n \nTh
 is event  has CPD accreditation and an open oral and poster session.  Abst
 racts can be submitted on any subject related to Alzheimer's Disease\n\nTh
 e deadline for abstract submissions for oral presentation is March 10th 20
 14.  Abstracts for poster presentation only can be submitted up to two wee
 ks before the event.  \nYou can download the instructions for authors at h
 ttp://www.euroscicon.com/ABSTRACTSUBMISSIONS.pdf\n\n*Program Outline*\n\n*
 Day 1: Biomarker Discovery and Assay Development*\nCurrently\, there are m
 any biomarkers for diagnosis of Alzheimer's disease. However most of them 
 do not provide consistent results.  This session will discuss current rese
 arch aimed at obtaining reliable biomarkers which could be used to diagnos
 e Alzheimer's disease at very early stage and also to provide objective an
 d reliable measures of disease progress.\n\n*Day 2:  Prevention Strategies
  and Vaccine Development* \nThis session will discuss current research int
 o Alzheimer's Disease prevention including vaccine development. There will
  be plenty of opportunity for discussion and debate.\n\n*Day 3:  Drug Disc
 overy and Development*\nThere are currently no treatments that will stop o
 r reverse the progress of Alzheimer’s disease. With an aging population 
 and increasing number of people with Alzheimer’s\, the need to develop w
 ays to halt and treat the disease have become paramount.  This session wil
 l discuss current research into Alzheimer’s drug discovery and developme
 nt including analysis of current clinical trials
LOCATION:Cineworld: The O2\, Peninsula Square\, London\, SE10 0DX
END:VEVENT
END:VCALENDAR